Recent advances in the understanding and treatment of acute myeloid leukemia [version 1; referees: 3 approved]
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease that has a poor prognosis. Recent advances in genomics and molecular biology have led to a greatly improved understanding of the disease. Until 2017, there had been no new drugs approved for AML in decades. Here, we r...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-08-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-1196/v1 |